Retinoic acid signaling during priming licenses intestinal CD103+ CD8 TRM cell differentiation

Zhijuan Qiu,Camille Khairallah,Timothy H. Chu,Jessica N. Imperato,Xinyuan Lei,Galina Romanov,Amha Atakilit,Lynn Puddington,Brian S. Sheridan
DOI: https://doi.org/10.1084/jem.20210923
2023-02-23
Journal of Experimental Medicine (JEM)
Abstract:CD8 tissue-resident memory T (T RM ) cells provide frontline protection at barrier tissues; however, mechanisms regulating T RM cell development are not completely understood. Priming dictates the migration of effector T cells to the tissue, while factors in the tissue induce in situ T RM cell differentiation. Whether priming also regulates in situ T RM cell differentiation uncoupled from migration is unclear. Here, we demonstrate that T cell priming in the mesenteric lymph nodes (MLN) regulates CD103 + T RM cell differentiation in the intestine. In contrast, T cells primed in the spleen were impaired in the ability to differentiate into CD103 + T RM cells after entry into the intestine. MLN priming initiated a CD103 + T RM cell gene signature and licensed rapid CD103 + T RM cell differentiation in response to factors in the intestine. Licensing was regulated by retinoic acid signaling and primarily driven by factors other than CCR9 expression and CCR9-mediated gut homing. Thus, the MLN is specialized to promote intestinal CD103 + CD8 T RM cell development by licensing in situ differentiation.
What problem does this paper attempt to address?